2017 (v1)
Journal article
Background: Systemic inflammatory and autoimmune diseases (SIADs) associated with myelodysplastic syndromes are often difficult to treat. Corticosteroids are efficient but only usually at high doses. The use of biologics needs to be specified.Methods: In a French multicenter retrospective study, we analyzed the efficacy and safety of biologics...
Uploaded on: February 28, 2023